Join me for a live webinar and Q&A session in June, when we will find out how organisations are managing integration with EMA’s Medical Literature Monitoring (EMA MLM) service and gaining a better understanding of the limitations.
The EMA MLM service has been operational for more than 18 months now and aims to reduce the duplication of efforts and the number of records entered into EudraVigilance for 400 established medicines.
Whilst there are many benefits of the service, such as improved efficiency and signal detection, uncertainties still exist among many MAHs about how they should incorporate this into their current pharmacovigilance workflows.
I will share with you some of our learning to date, based on discussions with our own customers over the last couple of years, and will present some of the integration options as case studies. I will also be on hand to answer your questions on this topic with a Q&A session.
For more details and to register for the webinar, please click here.
Photo credit: rs-photo / iStock